Pfizer and Jeil to extend distribution agreement with Lyrica

The distribution agreement made between Pfizer Korea and Jeil Pharm. Co. will expire on May 31, 2005 and therefore mutually agreed to extend it on April 28 for an ongoing distribution of Lipitor and Neurontin in addition to a new epileptic drug, Lyrica effective from June 1 this year.

Lipitor and Neurontin are major products of Pfizer, selling respectively 43.6 billion won and 41.9 billion w...